You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Encephalopathy due to beta-mercaptolactate-cysteine disulfiduria, look for clinical trials, and connect with others living with it — all in one place.
Open the full Encephalopathy due to beta-mercaptolactate-cysteine disulfiduria hub →Encephalopathy due to beta-mercaptolactate-cysteine disulfiduria is a rare condition. Also known as 3-mercaptopyruvate sulfurtransferase deficiency, Ampola syndrome, MCDU. Tomeko brings together the specialists, research, clinical trials, treatments and community for Encephalopathy due to beta-mercaptolactate-cysteine disulfiduria so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:1035 · OMIM 249650 · ICD-10 E72.1 · GARD 0000654
Start by learning the basics from an authoritative source, find a specialist or center that sees Encephalopathy due to beta-mercaptolactate-cysteine disulfiduria, and connect with a patient organization. Tomeko brings these together on one hub.
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Encephalopathy due to beta-mercaptolactate-cysteine disulfiduria, filtered to your area.
Tomeko shows live, recruiting studies for Encephalopathy due to beta-mercaptolactate-cysteine disulfiduria from ClinicalTrials.gov on the hub.